Navigation Links
ReShape Medical Appoints Robert E. Grant to Board of Directors
Date:6/21/2012

SAN CLEMENTE, Calif., June 21, 2012 /PRNewswire/ -- ReShape Medical, a company focused on a non-surgical weight loss device, announced today that Robert E. Grant will join its board of directors.

(Photo:  http://photos.prnewswire.com/prnh/20120621/LA28274)

Grant currently serves as chairman of Strathspey Crown LLC, a growth equity firm in Newport Beach focusing on lifestyle healthcare and cash-pay medical products. He is former president of the medical aesthetics division at Allergan Inc. in Irvine and most recently served as chief executive officer and president of Bausch+Lomb Surgical in Aliso Viejo. He brings extensive experience leading global medical device and pharmaceutical organizations.

"Robert is a visionary leader and strategist and we are delighted that he is joining the team," said Richard Thompson, ReShape Medical president and CEO. "His expertise with cash-pay, elective medical procedures will be invaluable as we move toward commercialization."  ReShape Medical is preparing to begin a pivotal clinical study to gain approval in the U.S. and launched commercially in Europe earlier this year.

Grant said, "I strongly believe there is a huge market opportunity for non-surgical weight loss devices and also that ReShape Medical is well positioned to be the market leader. I am honored to be joining the talented and experienced ReShape board."    

In addition to Grant, ReShape Medical's board of directors consists of: Ken Charhut (Chairman), President and CEO of Mindframe Inc.; Jeani Delagardelle, Managing Director of New Leaf Venture Partners; Casey Tansey, General Partner at US Venture Partners; David Milne, Managing Partner at SV Life Sciences; George Wallace, Managing General Partner for Intersect Partners LLC; and Richard Thompson, President and CEO of ReShape Medical.

About ReShape Medical, Inc.
ReShape Medical® is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients. ReShape Duo is a non-surgical alternative designed for those who have exhausted their efforts with diet alone and wish to avoid or do not qualify for surgery. It comfortably occupies existing space in the stomach for six months, serving as built in portion control, to help patients feel full and satisfied with less food. CAUTION - Limited by United States law to investigational use.


'/>"/>
SOURCE ReShape Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the latest ... Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... include new preclinical and clinical data on Bayer,s marketed portfolio ... pipeline projects. "We ... minds in cancer research at ESMO," said Carsten Brunn ...
(Date:8/29/2017)... , Aug. 29, 2017 In a ... security, and regulatory compliance for veterinary practices of all ... a new partnership that makes TITAN,s expertise in physical ... available to Cubex,s clients nationally. ... buying and handling controlled substances is at risk today," ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... a neurosurgeon, has received a big bump in sales after recently going ... currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, RevNutrition.com and Go4ItNutrition.com. ...
(Date:9/19/2017)... Glen Cove, New York (PRWEB) , ... September 19, 2017 , ... ... that its dentist, Dr. Andrew Sami, was recently named one of the best dentists ... the leading lifestyle magazine for dental professionals nationwide. Every fall, the magazine features the ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... update their mobile app offering. The new app provides a modern design with ... the overall shopping experience. , The fred’s Pharmacy mobile app includes hundreds of ...
(Date:9/18/2017)... ... September 19, 2017 , ... Food ... market , expected to grow at the fastest CAGR of 9.1% over the ... Food Protein Trends & Growth Opportunities in Asia’ – highlighting alternative proteins, sustainable ...
(Date:9/18/2017)... ... September 18, 2017 , ... Allegheny Health Network’s (AHN) string of standout ... fifth consecutive year, AHN earned more honors than any health care provider in the ... dinner Sept. 14 at the Omni William Penn Hotel in downtown Pittsburgh included:, ...
Breaking Medicine News(10 mins):